List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 27 studies with search of:   Open Studies | Australia, Australian Capital Territory
Include studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Radiotherapy Versus Radiotherapy Plus Chemotherapy in Early Stage Follicular Lymphoma
Condition: Follicular Lymphoma
Interventions: Drug: Cyclophosphamide;   Radiation: Radiotherapy;   Drug: Vincristine;   Drug: Prednisolone;   Drug: Rituximab
2 Recruiting PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Condition: Non Hodgkin Lymphoma
Interventions: Drug: enzastaurin;   Drug: placebo
3 Recruiting A Study of Abatacept in Patients With Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: abatacept;   Drug: placebo
4 Recruiting Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
Condition: Sepsis
Interventions: Drug: Drotrecogin alfa (activated);   Drug: Placebo
5 Recruiting A Study for Patients With Non-Hodgkin's Lymphomas
Conditions: T-Cell Lymphoma;   B-Cell Lymphoma
Intervention: Drug: enzastaurin
6 Recruiting Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
Conditions: Acute Coronary Syndrome;   Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention
Interventions: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin;   Drug: Plavix (clopidogrel 75 mg) and aspirin
7 Recruiting Once - Daily Oral Direct Factor Xa Inhibitor Rivaroxaban In The Long-Term Prevention Of Recurrent Symptomatic Venous Thromboembolism In Patients With Symptomatic Deep-Vein Thrombosis Or Pulmonary Embolism. The Einstein-Extension Study
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Placebo
8 Recruiting Efficacy and Safety of Adalimumab in Subjects With Moderately to Severely Acute Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: adalimumab;   Biological: placebo
9 Recruiting IN2SHAPE: A Study of Physical Activity and Depressive Symptoms in Adolescence
Condition: Depression
Interventions: Behavioral: Self-motivated physical activity;   Behavioral: Nutrition
10 Recruiting Deforolimus in Treatment of Sarcoma - SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Deforolimus)
Conditions: Metastatic Soft-Tissue Sarcomas;   Metastatic Bone Sarcomas
Interventions: Drug: deforolimus;   Drug: Placebo
11 Recruiting Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases
Condition: Bone Neoplasms
Intervention: Drug: Zoledronic acid
12 Recruiting Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin
13 Recruiting A Study of Abatacept in Patients With Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: abatacept;   Drug: placebo
14 Recruiting Randomized, Double-Blind Study Comparing Once Daily Oral Rivaroxaban With Adjusted-Dose Oral Warfarin for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Warfarin
15 Recruiting A Phase 1, Open-Label, Multiple-Dose, Dose Escalation Study of the Safety and Tolerability of Staphylococcal Protein A in Adult Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Condition: Idiopathic Thrombocytopenic Purpura (ITP)
Intervention: Drug: PRTX-100 (Staphylococcal protein A)
16 Recruiting Tifacogin for the Treatment of Patients With Severe Community-Acquired Pneumonia
Condition: Pneumonia
Intervention: Drug: Tifacogin
17 Recruiting Chlorambucil or Fludarabine as First-Line Therapy in Treating Patients With Previously Untreated Waldenström Macroglobulinemia, Splenic Lymphoma, or Lymphoplasmacytic Lymphoma
Condition: Lymphoma
Interventions: Drug: chlorambucil;   Drug: fludarabine phosphate;   Procedure: quality-of-life assessment
18 Recruiting A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-Like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to < 24 Month-Old Children and in 2 Month Old Infants
Conditions: Respiratory Syncytial Virus (RSV);   Parainfluenza Virus Type 3 (PIV3)
Interventions: Biological: MEDI-534;   Biological: MEDI-534;   Biological: MEDI-534;   Biological: MEDI-534;   Biological: MEDI-534;   Biological: Placebo
19 Recruiting Oral Direct Factor Xa Inhibitor Rivaroxaban In Patients With Acute Symptomatic Pulmonary Embolism With Or Without Symptomatic Deep-Vein Thrombosis: Einstein-PE Evaluation
Condition: Pulmonary Embolism
Interventions: Drug: Rivaroxaban (BAY59-7939);   Drug: Enoxaparin followed by VKE
20 Recruiting ACTiF- Assessment of Closed Tibial Fractures
Condition: Tibial Fractures
Interventions: Drug: CP-533, 536;   Drug: Placebo;   Procedure: Standard of Care;   Drug: CP-533,536

Previous Page Studies Shown (1-20) Next (21-27)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services